Literature DB >> 20038953

Stem cell research policy and iPS cells.

Timothy Caulfield1, Christopher Scott, Insoo Hyun, Robin Lovell-Badge, Kazuto Kato, Amy Zarzeczny.   

Abstract

Mesh：

Year:  2010        PMID： 20038953     DOI： 10.1038/nmeth.f.282

Source DB:  PubMed          Journal:  Nat Methods        ISSN： 1548-7091            Impact factor:   28.547


× No keyword cloud information.
  8 in total

1.  Mind the gap: policy approaches to embryonic stem cell and cloning research in 50 countries.

Authors:  Rosario M Isasi; Bartha M Knoppers
Journal:  Eur J Health Law       Date:  2006-04

2.  FDA regulation of stem-cell-based therapies.

Authors:  Dina Gould Halme; David A Kessler
Journal:  N Engl J Med       Date:  2006-10-19       Impact factor: 91.245

Review 3.  Why a criminal ban? Analyzing the arguments against somatic cell nuclear transfer in the Canadian parliamentary debate.

Authors:  Timothy Caulfield; Tania Bubela
Journal:  Am J Bioeth       Date:  2007-02       Impact factor: 11.229

4.  Informed consent in embryonic stem cell research: are we following basic principles?

Authors:  Timothy Caulfield; Ubaka Ogbogu; Rosario M Isasi
Journal:  CMAJ       Date:  2007-06-05       Impact factor: 8.262

5.  Stem cells: Fast and furious.

Authors:  Monya Baker
Journal:  Nature       Date:  2009-04-23       Impact factor: 49.962

6.  Human stem cell ethics: beyond the embryo.

Authors:  Jeremy Sugarman
Journal:  Cell Stem Cell       Date:  2008-06-05       Impact factor: 24.633

7.  Obtaining consent for future research with induced pluripotent cells: opportunities and challenges.

Authors:  Katriina Aalto-Setälä; Bruce R Conklin; Bernard Lo
Journal:  PLoS Biol       Date:  2009-02-24       Impact factor: 8.029

8.  Pluripotent stem cell-derived gametes: truth and (potential) consequences.

Authors:  Debra J H Mathews; Peter J Donovan; John Harris; Robin Lovell-Badge; Julian Savulescu; Ruth Faden
Journal:  Cell Stem Cell       Date:  2009-07-02       Impact factor: 24.633
  8 in total
  9 in total

1.  Stem cell banking: between traceability and identifiability.

Authors:  Bartha M Knoppers; Rosario Isasi
Journal:  Genome Med       Date:  2010-10-05       Impact factor: 11.117

2.  From embryonic stem cells to iPS - an ethical perspective.

Authors:  J Suaudeau
Journal:  Cell Prolif       Date:  2011-04       Impact factor: 6.831

3.  Stem cell policy exceptionalism: proceed with caution.

Authors:  Geoffrey P Lomax; Steven R Peckman
Journal:  Stem Cell Rev Rep       Date:  2012-06       Impact factor: 5.739

4.  A comparison of pluripotency and differentiation status of four mesenchymal adult stem cells.

Authors:  Fatemeh Jamshidi Adegani; Lida Langroudi; Ehsan Arefian; Abbas Shafiee; Peyman Dinarvand; Masoud Soleimani
Journal:  Mol Biol Rep       Date:  2012-12-29       Impact factor: 2.316

5.  Specimen collection for induced pluripotent stem cell research: harmonizing the approach to informed consent.

Authors:  Justin Lowenthal; Scott Lipnick; Mahendra Rao; Sara Chandros Hull
Journal:  Stem Cells Transl Med       Date:  2012-05-08       Impact factor: 6.940

Review 6.  LULL(ed) into complacency: a perspective on licenses and stem cell translational science.

Authors:  Mahendra S Rao
Journal:  Stem Cell Res Ther       Date:  2013-08-14       Impact factor: 6.832

7.  Responsible Translation of Stem Cell Research: An Assessment of Clinical Trial Registration and Publications.

Authors:  Moses Fung; Yan Yuan; Harold Atkins; Qian Shi; Tania Bubela
Journal:  Stem Cell Reports       Date:  2017-04-13       Impact factor: 7.765

Review 8.  Modelling urea cycle disorders using iPSCs.

Authors:  Claire Duff; Julien Baruteau
Journal:  NPJ Regen Med       Date:  2022-09-26

Review 9.  Donor information in research and drug evaluation with induced pluripotent stem cells (iPSCs).

Authors:  Marcin Orzechowski; Maximilian Schochow; Michael Kühl; Florian Steger
Journal:  Stem Cell Res Ther       Date:  2020-03-19       Impact factor: 6.832
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.